TABLE 1.

Clinical Pseudomonas aeruginosa isolates, laboratory strains, and plasmids used in this study.

Name	Description/genotype	References
Clinical isolates
PA KR794	Urine isolate	Paulsson et al., 2015
PA KR796	Airway isolate from a patient with CF	Paulsson et al., 2015
PA KR799	Blood isolate	Paulsson et al., 2015
PA KR801	Airway isolate from a patient with CF	Paulsson et al., 2015
Laboratory strains
E. coli BL21(DE3)	E. coli laboratory strain	Studier and Moffatt, 1986
E. coli DH5α	E. coli laboratory strain	Taylor et al., 1993
E. coli pET16b-pba	E. coli BL21(DE3) for soluble expression of Pba	This study
E. coli pET16b-oprG	E. coli BL21(DE3) for soluble expression of OprG	Paulsson et al., 2019
PAO1	P. aeruginosa reference strain	Held et al., 2012
PW2884	PAO1 mutant with ISlacZ/hah transposon insert in pba	Held et al., 2012
PW2884 + pba	PW2884 complemented with pUCP22Not-pba	This study
Plasmids
pUCP22Not-pba	Complementation plasmid with PA1041 insert. Gentamicinr	Herrero et al., 1990
pET16b-pba	6 × His-tagged Pba expression vector. Ampicillinr	This study
pMRP9	GFP expression vector. Carbenicillinr	Davies et al., 1998